Neuropathy in the feet/t the neuropathy on her feet that happened 2 week after the vaccine; started experiencing tingling; numbness in my feet.; Hemochromatosis; 1st dose 21 jan, 2nd dose 26 feb; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPATHY PERIPHERAL (Neuropathy in the feet/t the neuropathy on her feet that happened 2 week after the vaccine), PARAESTHESIA (started experiencing tingling), HYPOAESTHESIA (numbness in my feet.), HAEMOCHROMATOSIS (Hemochromatosis) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 21 jan, 2nd dose 26 feb) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hemochromatosis since 15-Dec-2018 and Drug allergy (sulfa allergy). Concomitant products included MULTIVITAMIN [VITAMINS NOS], CALCIUM from 2015 to an unknown date, MAGNESIUM from 2015 to an unknown date and VITAMIN D [VITAMIN D NOS] from 2015 to an unknown date for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 21 jan, 2nd dose 26 feb). In March 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PARAESTHESIA (started experiencing tingling), HYPOAESTHESIA (numbness in my feet.) and HAEMOCHROMATOSIS (Hemochromatosis). In April 2021, the patient experienced NEUROPATHY PERIPHERAL (Neuropathy in the feet/t the neuropathy on her feet that happened 2 week after the vaccine). The patient was treated with Manual therapy (Acupuncture using chinese medicines) for Neuropathy peripheral. On 26-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 21 jan, 2nd dose 26 feb) had resolved. At the time of the report, NEUROPATHY PERIPHERAL (Neuropathy in the feet/t the neuropathy on her feet that happened 2 week after the vaccine) was resolving and PARAESTHESIA (started experiencing tingling), HYPOAESTHESIA (numbness in my feet.) and HAEMOCHROMATOSIS (Hemochromatosis) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient started experiencing events 2 weeks post second dose of vaccine and was treated by a doctor for a neuropathy in feet, patient reported that hemochromatosis is when there was excess iron in the feet. Treatment used Acupuncture. When he had symptoms of tingling and numbness in feet he thought as Planter Fasciitis and treated it accordingly. and he visited neurologist in April he diagnosed as peripheral neuropathy.   Most recent FOLLOW-UP information incorporated above includes: On 30-Nov-2021: Follow-up received Contains significant information-Updated patient demographics, allergies and current medical history, concomitant medications, added new event and outcome of events. On 30-Nov-2021: Follow-up received and contains no new information. On 30-Nov-2021: Follow up received contains Significant information-New Reporter information. On 01-Dec-2021: Non-Significant Follow up-Document attached On 02-Dec-2021: Follow up contains Significant information: Event was clubbed and verbatim updated. On 02-Dec-2021: Non Significant Follow Up;